ReproCell Inc 4978.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
193.00UNCH (UNCH)
Volume
455,000
52 week range
187.00 - 420.00
Loading...
  • Open188.00
  • Day High194.00
  • Day Low188.00
  • Prev Close193.00
  • 52 Week High420.00
  • 52 Week High Date05/21/21
  • 52 Week Low187.00
  • 52 Week Low Date05/17/22

Key Stats

  • Market Cap128.58M
  • Shares Out82.24M
  • 10 Day Average Volume722,966.67
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-18.22

KEY STATS

  • Open188.00
  • Day High194.00
  • Day Low188.00
  • Prev Close193.00
  • 52 Week High420.00
  • 52 Week High Date05/21/21
  • 52 Week Low187.00
  • 52 Week Low Date05/17/22
  • Market Cap128.58M
  • Shares Out82.24M
  • 10 Day Average Volume722,966.67
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-18.22

RATIOS/PROFITABILITY

  • EPS (TTM)-1.70
  • P/E (TTM)-113.53
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ReproCell Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical...
Chikafumi Yokoyama
President, Chief Executive Officer of Subsidiary, Representative Director
Daisuke Usui
Chief Financial Officer, Director
Address
9F, KDX Shin-Yokohama 381 Bldg.
3-8-11, Shin-Yokohama, Kohoku-ku
Yokohama-shi, KNG
222-0033
Japan